Since the recognition of angiotensin-converting enzyme inhibitors (ACEIs)-induced cough, drug has been considered as a potential cause of chronic cough. This review presents recent knowledge on drug-induced coughs in patients with chronic cough. The focus is placed on ACEIs, for which there are a multitude of studies documenting their associations with cough. Additional drugs are discussed for which there are reports of cough as a side effect of treatment, and the potential mechanisms of these effects are discussed.

Department of Internal Medicine Ewha Womans University College of Medicine Seoul

Zobrazit více v PubMed

AGARWAL A, AZIM A, AMBESH S, BOSE N, DHIRAJ S, SAHU D, SINGH U. Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by iv fentanyl. Can J Anaesth. 2003;50:297–300. doi: 10.1007/BF03017801. PubMed DOI

AHREN B, JOHNSON SL, STEWART M, CIRKEL DT, YANG F, PERRY C, FEINGLOS MN HARMONY STUDY GROUP. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin. Diabetes Care. 2014;37:2141–2148. doi: 10.2337/dc14-0024. PubMed DOI

AI Q, HU Y, WANG Y, WU S, QIN Z, WANG J, WANG G, ZHANG J, AN M. Pentazocine pretreatment suppresses fentanyl-induced cough. Pharmacol Rep. 2010;62:747–750. doi: 10.1016/S1734-1140(10)70333-9. PubMed DOI

ALHARBI FF, KHOLOD AAV, SOUVEREIN PC, MEYBOOM RH, DE GROOT MCH, DE BOER A, KLUNGEL OH. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors, a case/noncase study in VigiBase. Fundam Clin Pharmacol. 2017;31:676–684. doi: 10.1111/fcp.12313. PubMed DOI

ARJONA FERREIRA JC, CORRY D, MOGENSEN CE, SLOAN L, XU L, GOLM GT, GONZALEZ EJ, DAVIES MJ, KAUFMAN KD, GOLDSTEIN BJ. Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis. 2013;61:579–587. doi: 10.1053/j.ajkd.2012.11.043. PubMed DOI

BAKER-SMITH CM, BENJAMIN DK, CALIFF RM, MURPHY MD, LI JS, SMITH PB. Cough in pediatric patients receiving angiotensin-converting enzyme inhibitor therapy or angiotensin receptor blocker therapy in randomized controlled trials. Clin Pharmacol Ther. 2010;87:668–671. doi: 10.1038/clpt.2009.231. PubMed DOI PMC

BARANIUK JN, JAMIESON MJ. Rhinorrhea, cough and fatigue in patients taking sitagliptin. Allergy Asthma Clin Immunol. 2010;6:8. doi: 10.1186/1710-1492-6-8. PubMed DOI PMC

BART BA, ERTL G, HELD P, KUCH J, MAGGIONI AP, McMURRAY J, MICHELSON EL, ROULEAU JL, WARNER L, STEVENSON K, SWEDBERG J, YOUNG B, YUSUF S, SELLERS MA, GRANGER CB, CALIFF RM, PFEFFER MA. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J. 1999;20:1182–1190. doi: 10.1053/euhj.1998.1481. PubMed DOI

BERTRAND ME. Provision of cardiovascular protection by ACE inhibitors: a review of recent trials. Curr Med Res Opin. 2004;20:1559–1569. doi: 10.1185/030079904X4185. PubMed DOI

BOHRER HF, FLEISCHER F, WERNING P. Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia. 1990;45:18–21. doi: 10.1111/j.1365-2044.1990.tb14496.x. PubMed DOI

BRUGTS JJ, ARIMA H, REMME W, BERTRAND M, FERRARI R, FOX K, DINICOLANTONIO J, MACMAHON S, CHALMERS J, ZIJLSTRA F, CALISKAN K, SIMOONS ML, MOURAD JJ, BOERSMA E, AKKERHUIS KM. The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease. Int J Cardiol. 2014;176:718–723. doi: 10.1016/j.ijcard.2014.07.108. PubMed DOI

CAI LY, CAI Z, LU J, ZHANG Y, LIU P. The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. J Clin Pharm Ther. 2012;37:386–398. doi: 10.1111/j.1365-2710.2011.01323.x. PubMed DOI

CALDEIRA D, DAVID C, SAMPAIO C. Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis. Am J Cardiovasc Drugs. 2012;12:263–277. doi: 10.1007/BF03261835. PubMed DOI

CHARBONNEL B, KARASIK A, LIU J, WU M, MEININGER G GROUP SITAGLIPTIN STUDY. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone. Diabetes Care. 2006;29:2638–2643. doi: 10.2337/dc06-0706. PubMed DOI

DASHTI-KHAVIDAKI S, FAGHIHI T, AHMADI F, KHALILI H. Cough induced by losartan with resolution after substitution with enalapril. Clin Ther. 2008;30:548–551. doi: 10.1016/j.clinthera.2008.03.003. PubMed DOI

DICPINIGAITIS PV. Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:169–73. doi: 10.1378/chest.129.1_suppl.169S. PubMed DOI

DOUCET J, CHACRA A, MAHEUX P, LU J, HARRIS S, OSENSTOCK R. Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus. Curr Med Res Opin. 2011;27:863–869. doi: 10.1185/03007995.2011.554532. PubMed DOI

DUBE SK, RATH GP. Cough and bronchospasm after rapid intravenous administration of phenytoin. J Neurosurg Anesthesiol. 2012;24:239–240. doi: 10.1097/ANA.0b013e318259b46a. PubMed DOI

DYKEWICZ MS. Cough and angioedema from angiotensin-converting enzyme inhibitors: new insights into mechanisms and management. Curr Opin Allergy Clin Immunol. 2004;4:267–270. doi: 10.1097/01.all.0000136759.43571.7f. PubMed DOI

EDWARDS CR, PADFIELD PL. Angiotensin-converting enzyme inhibitors: past, present, and bright future. Lancet. 1985;1:30–34. doi: 10.1016/S0140-6736(85)90975-4. PubMed DOI

EL-HASHIM AZ, AMINES A. The role of substance P and bradykinin in the cough reflex and bronchoconstriction in guinea-pigs. Eur J Pharmacol. 2005;513:125–133. doi: 10.1016/j.ejphar.2005.02.007. PubMed DOI

ELLI A, AROLDI A, MONTAGNINO G, TARANTINO A, PONTICELLI C. Mycophenolate mofetil and cough. Transplantation. 1998;66:409. doi: 10.1097/00007890-199808150-00026. PubMed DOI

ENGEL SS, ROUND E, GOLM GT, KAUFMAN KD, GOLDSTEIN BJ. Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies. Diabetes Ther. 2013;4:119–145. doi: 10.1007/s13300-013-0024-0. PubMed DOI PMC

FAHIM A, MORICE AH. Heightened cough sensitivity secondary to latanoprost. Chest. 2009;136:1406–07. doi: 10.1378/chest.09-0070. PubMed DOI

FAZAL K, PERERA G, KHONDOKER M, HOWARD R, STEWART R. Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer’s disease. BJPsych open. 2017;3:158–164. doi: 10.1192/bjpo.bp.116.004184. PubMed DOI PMC

HALLBERG P, PERSSON M, AXELSSON T, CAVALLI M, NORLING P, JOHANSSON JE, YUE YJ, MAGNUSSON PK, WADELIUS C, ERIKSSON N, WADELIUS M. Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population. Pharmacogenomics. 2017;18:201–213. doi: 10.2217/pgs-2016-0184. PubMed DOI

HEWITT M, ADAMS G, MAZZONE SB, MORI N, YU L, CANNING BJ. Pharmacology of BRADYKININ-EVOKED COUGHING IN GUINEA PIGS. J PHARMACOL EXP THER. 2016;357:620–628. doi: 10.1124/jpet.115.230383. PubMed DOI PMC

HOWAIZI M, DELAFOSSE C. Omeprazole-induced intractable cough. Ann Pharmacother. 2003;37:1607–1609. doi: 10.1345/aph.1D185. PubMed DOI

HUGHES J, LOCKHART J, JOYCE A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br J Clin Pharmacol. 2007;64:83–89. doi: 10.1111/j.1365-2125.2007.02851.x. PubMed DOI PMC

HUMBERT X, ALEXANDRE J, SASSIER M, DEFAULT A, GOURAUD A, YELEHE-OKOUMA M, PUDDU PE, FEDRIZZI S. Long delay to onset of ACE inhibitors-induced cough: Reason of difficult diagnosis in primary care? Eur J Intern Med. 2017;37:50–51. doi: 10.1016/j.ejim.2016.10.006. PubMed DOI

IGNJATOVIC T, TAN F, BROVKOVYCH V, SKIDGEL RA, ERDOS EG. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem. 2002;277:16847–16852. doi: 10.1074/jbc.M200355200. PubMed DOI

IRWIN RS, FRENCH CL, CHANG AB, ALTMAN KW, ADAMS TM, AZOULAY E, BARKER AF, BIRRING SS, BLACKHALL F, BOLSER DC. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153:196–209. doi: 10.1016/j.chest.2017.10.016. PubMed DOI PMC

JAFAR TH, SCHMID CH, LANDA M, GIATRAS I, TOTO R, REMUZZI G, MASCHIO G, BRENNER BM, KAMPER A, ZUCCHELLI P, BECKER G, HIMMELMANN A, BANNISTER K, LANDAIS P, SHAHINFAR S, de JONG PE, de ZEEUW D, LAU J, LEVEY AS. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87. doi: 10.7326/0003-4819-135-2-200107170-00007. PubMed DOI

KAHRILAS PJ, HOWDEN CW, HUGHES N, MOLLOY-BLAND M. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143:605–612. doi: 10.1378/chest.12-1788. PubMed DOI PMC

KAMEI J, NAKANISHI Y, ASATO M, IKEDA H. Fentanyl enhances the excitability of rapidly adapting receptors to cause cough via the enhancement of histamine release in the airways. Cough. 2013;9:3. doi: 10.1186/1745-9974-9-3. PubMed DOI PMC

KAUFMAN J, CASANOVA JE, RIENDL P, SCHLUETER DP. Bronchial hyperreactivity and cough due to angiotensin-converting enzyme inhibitors. Chest. 1989;95:544–548. doi: 10.1378/chest.95.3.544. PubMed DOI

KAUFMAN J, SCHMITT S, BARNARD J, BUSSE W. Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest. 1992;101:922–925. doi: 10.1378/chest.101.4.922. PubMed DOI

KIM NH, YU T, LEE DH. The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. Biomed Res Int. 2014;2014:368703. doi: 10.1155/2014/368703. PubMed DOI PMC

KIM YS, PARK HS, SUNWOO S, BYEON JJ, SONG YM, SEO HG, KIM CH, CHEON KS, YOO SM, LEE JK GROUP KOREA POST-MARKETING SURVEILLANCE RESEARCH. Short-term safety and tolerability of antihypertensive agents in Korean patients: an observational study. Pharmacoepidemiol Drug Saf. 2000;9:603–609. doi: 10.1002/pds.554. PubMed DOI

KLIMKO PG, SHARIF NA. Discovery, characterization and clinical utility of prostaglandin agonists for the treatment of glaucoma. Br J Pharmacol. 2019;176:1051–1058. doi: 10.1111/bph.14327. PubMed DOI PMC

LAINEZ MJ, FREITAG FG, PFEIL J, ASCHER S, OLSON WH, SCHWALEN S. Time course of adverse events most commonly associated with topiramate for migraine prevention. Eur J Neurol. 2007;14:900–906. doi: 10.1111/j.1468-1331.2007.01869.x. PubMed DOI

LEE YJ, TSAI JC. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism. 2001;50:1346–1350. doi: 10.1053/meta.2001.27212. PubMed DOI

LEHRKE M, MARX N, PATEL S, SECK T, CROWE S, CHENG K, von EYNATTEN M, JOHANSEN OE. Safety and tolerability of linagliptin in patients with Type 2 diabetes: A comprehensive pooled analysis of 22 placebo-controlled studies. Clin Ther. 2014;36:1130–1146. doi: 10.1016/j.clinthera.2014.06.008. PubMed DOI

LI EC, HERAN BS, WRIGHT JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2014:CD009096. doi: 10.1002/14651858.CD009096.pub2. PubMed DOI PMC

LI YF, ZHU XM, LIU F, XIAO CS, BIAN YF, LI H, CAI J, LI RS, YANG XC. Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis. PLoS One. 2012;7:e37396. doi: 10.1371/journal.pone.0037396. PubMed DOI PMC

MAGGIONI F, MAMPRESO E, MAINARDI F, LISOTTO C, MALVINDI ML, ZANCHIN G. Topiramate-induced intractable cough during migraine prophylaxis. Headache. 2010;50:301–304. doi: 10.1111/j.1526-4610.2009.01515.x. PubMed DOI

MAHMOUDPOUR SH, VELUCHAMY A, SIDDIQUI MK, ASSELBERGS FW, SOUVEREIN PC, de KEYSER CE, HOFMAN A, LANG CC, DONEY AS, STRICKER BH, de BOER A, MAITLAND-van der ZEE AH, PALMER CN. Meta-analysis of genome-wide association studies on the intolerance of angiotensin-converting enzyme inhibitors. Pharmacogenet Genomics. 2017;27:112–119. doi: 10.1097/FPC.0000000000000264. PubMed DOI PMC

MATCHAR DB, McCRORY DC, ORLANDO LA, PATEL MR, PATEL UD, PATWARDHAN MB, POWERSB, SAMSA GP, GRAY RN. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med. 2008;148:16–29. doi: 10.7326/0003-4819-148-1-200801010-00189. PubMed DOI

McDOWELL SE, COLEMAN JJ, FERNER RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177–1181. doi: 10.1136/bmj.38803.528113.55. PubMed DOI PMC

MEDFORD AR. A 54 year-old man with a chronic cough – Chronic cough: don’t forget drug-induced causes. Prim Care Respir J. 2012;21:347–348. doi: 10.4104/pcrj.2012.00078. PubMed DOI PMC

MORICE AH, JAKES AD, FARUQI S, BIRRING SS, MCGARVEY L, CANNING BJ, SMITH JA, PARKER SM, CHUNG KF, LAI K, PAVORD ID, VAN DEN BERG J, SONG WJ, MILLQVIST E, FARRELL MJ, MAZZONE SB, DICPINIGAITIS P REGISTRY CHRONIC COUGH. A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response. Eur Respir J. 2014;44:1149–1155. doi: 10.1183/09031936.00217813. PubMed DOI

MORICE AH, LOWRY R, BROWN MJ, HIGENBOTTAM T. Angiotensin-converting enzyme and the cough reflex. Lancet. 1987;2:1116–8. doi: 10.1016/S0140-6736(87)91547-9. PubMed DOI

MORICE AH, McGARVEY L, PAVORD I. Recommendations for the management of cough in adults. Thorax. 2006;61(Suppl 1):i1–24. doi: 10.1136/thx.2006.065144. PubMed DOI PMC

MORICE AH, MILLQVIST E, BELVISI MG, BIEKSIENE K, BIRRING SS, CHUNG KF, DAL NEGRO RW, DICPINIGAITIS P, KANTAR A, MCGARVEY LP. Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J. 2014;44:1132–1148. doi: 10.1183/09031936.00218613. PubMed DOI

MORICE AH, MILLQVIST E, BIEKSIENE K, BIRRING SS, DICPINIGAITIS P, RIBAS CD, BOON MH, KANTAR A, LAI K, McGARVEY L, RIGAU D, SATIA I, SMITH J, SONG JW, TONIA T, van den BERG JWK, van MANEN MJG, ZACHARASIEWICZ A. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55 doi: 10.1183/13993003.01136-2019. pii:1901136. PubMed DOI PMC

MORIMOTO T, GANDHI TK, FISKIO JM, SEGER AC, SO JW, COOK EF, FUKUI T, BATES DW. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract. 2004;10:499–509. doi: 10.1111/j.1365-2753.2003.00484.x. PubMed DOI

MUKAE S, AOKI S, ITOH S, IWATA T, UEDA H, KATAGIRI T. Bradykinin B2 receptor gene polymorphism is associated with angiotensin-converting enzyme inhibitor-related cough’. Hypertension. 2000;36:127–131. doi: 10.1161/01.HYP.36.1.127. PubMed DOI

MUKAE S, ITOH S, AOKI S, IWATA T, NISHIO K, SATO R, KATAGIRI T. Association of polymorphisms of the renin-angiotensin system and bradykinin B2 receptor with ACE-inhibitor-related cough. J Hum Hypertens. 2002;16:857–863. doi: 10.1038/sj.jhh.1001486. PubMed DOI

NASCIMENTO FA, TAKESHITA BT, KOWACS PA. Phenytoin-induced isolated chronic, nocturnal dry cough. Epilepsy Behav Case Rep. 2016;5:44–45. doi: 10.1016/j.ebcr.2016.03.002. PubMed DOI PMC

NICHOL G, NIX A, BARNES PJ, CHUNG KF. Prostaglandin F2 alpha enhancement of capsaicin induced cough in man: modulation by beta 2 adrenergic and anticholinergic drugs. Thorax. 1990;45:694–698. doi: 10.1136/thx.45.9.694. PubMed DOI PMC

NIKPOOR B, DUAN QL, ROULEAU GA. Acute adverse reactions associated with angiotensin-converting enzyme inhibitors: genetic factors and therapeutic implications. Expert Opin Pharmacother. 2005;6:1851–1856. doi: 10.1517/14656566.6.11.1851. PubMed DOI

O’CONNELL F, THOMAS WE, PRIDE NB, FULLER RW. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 1994;150:374–380. doi: 10.1164/ajrccm.150.2.8049818. PubMed DOI

OS I, BRATLAND B, DAHLOF B, GISHOLT K, SYVERTSEN JO, TRETLI S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens. 1994;7:1012–1015. doi: 10.1093/ajh/7.11.1012. PubMed DOI

PACKARD KA, WURDEMAN RL, AROUNI AJ. ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction. Ann Pharmacother. 2002;36:1058–1067. doi: 10.1345/aph.1A332. PubMed DOI

PARK HK, OH SY, KIM TB, BAHN JW, SHIN ES, LEE JE, OH HB, KIM YK, PARK T, CHO SH, MIN KU, KIM YY. Association of genetic variations in neurokinin-2 receptor with enhanced cough sensitivity to capsaicin in chronic cough. Thorax. 2006;61:1070–1075. doi: 10.1136/thx.2005.054429. PubMed DOI PMC

PARMAR MS. Exacerbation of asthma secondary to fentanyl transdermal patch. BMJ Case Rep. 2009;2009 doi: 10.1136/bcr.10.2008.1062. pii: bcr10.2008.1062. PubMed DOI PMC

RAVID D, LISHNER M, LANG R, RAVID M. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J Clin Pharmacol. 1994;34:1116–1120. doi: 10.1002/j.1552-4604.1994.tb01989.x. PubMed DOI

REICHE I, TROGER U, MARTENS-LOBENHOFFER J, KANDULSKI A, NEUMANN H, MALFERTHEINER P, BODE-BOGER SM. Omeprazole-induced cough in a patient with gastroesophageal reflux disease. Eur J Gastroenterol Hepatol. 2010;22:880–882. doi: 10.1097/MEG.0b013e3283320129. PubMed DOI

REISIN L, SCHNEEWEISS A. Complete spontaneous remission of cough induced by ACE inhibitors during chronic therapy in hypertensive patients. J Hum Hypertens. 1992;6:333–335. PubMed

SALEH AJ, ZHANG L, HADI SM, OUYANG W. A priming dose of intravenous ketamine-dexmedetomidine suppresses fentanyl-induced coughing: a double-blind, randomized, controlled study. Ups J Med Sci. 2014;119:333–337. doi: 10.3109/03009734.2014.968270. PubMed DOI PMC

SATO A, FUKUDA S. A prospective study of frequency and characteristics of cough during ACE inhibitor treatment. Clin Exp Hypertens. 2015;37:563–568. doi: 10.3109/10641963.2015.1026040. PubMed DOI

SCHNABEL AK, DALHOFF S, BAUERFEIND J, GROSS WL. Sustained cough in methotrexate therapy for rheumatoid arthritis. Clin Rheumatol. 1996;15:277–282. doi: 10.1007/BF02229707. PubMed DOI

SEKIZAWA K, EBIHARA T, SASAKI H. Role of substance P in cough during bronchoconstriction in awake guinea pigs. Am J Respir Crit Care Med. 1995;151:815–821. doi: 10.1164/ajrccm.151.3.7533603. PubMed DOI

SEMPLE PF, HERD GW. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N Engl J Med. 1986;314:61. doi: 10.1056/NEJM198601023140119. PubMed DOI

SESOKO S, KANEKO Y. Cough associated with the use of captopril. Arch Intern Med. 1985;145:1524–1524. doi: 10.1001/archinte.145.8.1524. PubMed DOI

SHIOBARA T, CHIBANA K, WATANABE T, ARAI R, HORIGANE Y, NAKAMURA Y, HAYASHI Y, SHIMIZU Y, TAKEMASA A, ISHII Y. Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells. Respir Res. 2016;17:28. doi: 10.1186/s12931-016-0342-7. PubMed DOI PMC

SHUYING L, PING L, JUAN N, DONG L. Different interventions in preventing opioid-induced cough: a meta-analysis. J Clin Anesth. 2016;34:440–447. doi: 10.1016/j.jclinane.2016.05.034. PubMed DOI

SILBERSTEIN SD. Topiramate in migraine prevention: a 2016 perspective. Headache. 2017;57:165–178. doi: 10.1111/head.12997. PubMed DOI

SMITH J, ALLMAN D, BADRI H, MILLER R, MORRIS J, SATIA I, WOOD A, TROWER M. The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough: results from a Phase 2 Pilot Study (VOLCANO-1) Chest. 2020;157:111–118. doi: 10.1016/j.chest.2019.08.001. PubMed DOI

SONG DJ, SONG WJ, KWON JW, KIMGW, KIM MA, KIM MY, KIM MH, KIM SH, KIM ST, KIM SH, KIM JK, KIM JH, KIM HJ, KIM HB, PARK KH, YOON JK, LEE BJ, LEE SE, LEE YM, LEE YJ, LIM KH, JEON YH, JO EJ, JEE YK, JIN HJ, CHOI SH, HUR GY, CHO SH, KIM SH, LIM DH. KAAACI Evidence-based clinical practice guidelines for chronic cough in adults and children in Korea. Allergy Asthma Immunol Res. 2018;10:591–613. doi: 10.4168/aair.2018.10.6.591. PubMed DOI PMC

SONG WJ, MORICE AH. Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res. 2017;9:394–402. doi: 10.4168/aair.2017.9.5.394. PubMed DOI PMC

SONG WJ, WON HK, AN J, KANG SY, JO EJ, CHANG YS, LEE BJ, CHO SH. Chronic cough in the elderly. Pulm Pharmacol Ther. 2019;56:63–68. doi: 10.1016/j.pupt.2019.03.010. PubMed DOI

STONE RP, BARNES J, FULLER RW. Contrasting effects of prostaglandins E2 and F2 alpha on sensitivity of the human cough reflex. J Appl Physiol. 1992;73:649–653. doi: 10.1152/jappl.1992.73.2.649. PubMed DOI

TOSUN E, TOPALOGLU O, AKKALYONCU B. As a rare cause of drug-induced cough: topiramate. Acta Neurol Belg. 2012;112:217–220. doi: 10.1007/s13760-012-0016-2. PubMed DOI

TRIFILIEFF A, DA SILVA A, GIES JP. Kinins and respiratory tract diseases. Eur Respir J. 1993;6:576–587. PubMed

TSOU CH, LUK HN, CHIANG SC, HSIN ST, WANG JH. Fentanyl-induced coughing and airway hyperresponsiveness. Acta Anaesthesiol Sin. 2002;40:165–172. PubMed

UJIIE Y, SEKIZAWA K, AIKAWA T, SASAKI H. Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am J Respir Crit Care Med. 1993;148:1628–1632. doi: 10.1164/ajrccm/148.6_Pt_1.1628. PubMed DOI

VEGTER S, BOER P, VAN DIJK KW, VISSER S. The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis. Drug Safety. 2013;36:435–439. doi: 10.1007/s40264-013-0024-z. PubMed DOI

VISSER LE, STRICKER BH, VELDEN JD, PAES AH, BAKKER A. Angiotensin converting enzyme inhibitor associated cough: a population-based case-control study. J Clin Epidemiol. 1995;48:851–857. doi: 10.1016/0895-4356(94)00231-E. PubMed DOI

VUKADINOVIC D, VUKADINOVIC AN, LAVALL D, LAUFS U, WAGENPFEIL S, BOHM M. Rate of cough during treatment with angiotensin-converting enzyme inhibitors: a meta-analysis of randomized placebo-controlled trials. Clin Pharmacol Ther. 2019;105:652–660. doi: 10.1002/cpt.1018. PubMed DOI

WILLIAMS-HERMAN D, ENGEL SS, ROUND E, JOHNSONJ, GOLM GT, MUSSER BJ, DAVIES MJ, KAUFMAN KD, GOLDSTEIN BJ. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord. 2010;10:7. doi: 10.1186/1472-6823-10-7. PubMed DOI PMC

WOO SW, BANG S, CHUNG MW, JIN SK, KIMYS, LEE SH. Lack of association between ACE and bradykinin B2 receptor gene polymorphisms and ACE inhibitor-induced coughing in hypertensive Koreans. J Clin Pharm Ther. 2009;34:561–567. doi: 10.1111/j.1365-2710.2009.01028.x. PubMed DOI

YUN S, GESSNER R, DIETEL C, SCHMIEDEK U, FAN H. Enhanced ovalbumin-induced airway inflammation in CD26−/− mice. Eur J Immunol. 2012;42:533–540. doi: 10.1002/eji.201041038. PubMed DOI

YILMAZ I. Angiotensin-converting enzyme inhibitors induce cough. Turk Thorac J. 2019;20:36–42. doi: 10.5152/TurkThoracJ.2018.18014. PubMed DOI PMC

YUSUF S, PITT B, DAVIS CE, HOOD WB, COHN JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302. doi: 10.1056/NEJM199108013250501. PubMed DOI

Legacy of Prof. Juraj Korpáš: International Impact of Slovak School of Experimental Respirology